colorectal cancer
Conditions
Interventions
control group:None
Sponsors
Hangzhou Linping Hospital of Integrated Traditional Chinese and Western Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients whose specimens were obtained through endoscopic biopsy or surgical resection and who were pathologically diagnosed with colorectal cancer. 2.Healthy subjects all underwent complete colonoscopy, which showed no abnormalities, and the pathological examination of biopsied intestinal mucosal tissue was also unremarkable. 3.Complete clinical data.
Exclusion criteria
Exclusion criteria: 1.A complete colonoscopy was not performed on the healthy subjects, with the endoscope not reaching the ileocecal region. 2.Patients with other concurrent tumors, hematological diseases, severe hepatic or renal insufficiency, severe diseases, or multiple underlying diseases. 3.Patients who have received radiotherapy or chemotherapy, or have participated in clinical trials in the past 3 months. 4.Patients with mental disorders caused by other reasons. 5.Patients with incomplete personal information or clinical data, incomplete data, and those lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TL1A expression level; | — |
Countries
China
Contacts
Public ContactZhu Sihui
Hangzhou Linping Hospital of Integrated Traditional Chinese and Western Medicine
Outcome results
None listed